Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here:

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Paul Franks

Paul Franks

Principal investigator

Paul Franks

Rare Functional Variant in TM2D3 is Associated with Late-Onset Alzheimer's Disease


  • Johanna Jakobsdottir
  • Sven J. van der Lee
  • Joshua C. Bis
  • Vincent Chouraki
  • David Li-Kroeger
  • Shinya Yamamoto
  • Megan L. Grove
  • Adam Naj
  • Maria Vronskaya
  • Jose L. Salazar
  • Anita L. DeStefano
  • Jennifer A. Brody
  • Albert V. Smith
  • Najaf Amin
  • Rebecca Sims
  • Carla A. Ibrahim-Verbaas
  • Seung Hoan Choi
  • Claudia L. Satizabal
  • Oscar L. Lopez
  • Alexa Beiser
  • M. Arfan Ikram
  • Melissa E. Garcia
  • Caroline Hayward
  • Tibor V. Varga
  • Samuli Ripatti
  • Paul W. Franks
  • Göran Hallmans
  • Olov Rolandsson
  • Jan Håkon Jansson
  • David J. Porteous
  • Veikko Salomaa
  • Gudny Eiriksdottir
  • Kenneth M. Rice
  • Hugo J. Bellen
  • Daniel Levy
  • Andre G. Uitterlinden
  • Valur Emilsson
  • Jerome I. Rotter
  • Thor Aspelund
  • Christopher J. O’Donnell
  • Annette L. Fitzpatrick
  • Lenore J. Launer
  • Albert Hofman
  • Li San Wang
  • Julie Williams
  • Gerard D. Schellenberg
  • Eric Boerwinkle
  • Bruce M. Psaty
  • Sudha Seshadri
  • Joshua M. Shulman
  • Vilmundur Gudnason
  • Cornelia M. van Duijn

Summary, in English

We performed an exome-wide association analysis in 1393 late-onset Alzheimer’s disease (LOAD) cases and 8141 controls from the CHARGE consortium. We found that a rare variant (P155L) in TM2D3 was enriched in Icelanders (~0.5% versus <0.05% in other European populations). In 433 LOAD cases and 3903 controls from the Icelandic AGES sub-study, P155L was associated with increased risk and earlier onset of LOAD [odds ratio (95% CI) = 7.5 (3.5–15.9), p = 6.6x10-9]. Mutation in the Drosophila TM2D3 homolog, almondex, causes a phenotype similar to loss of Notch/Presenilin signaling. Human TM2D3 is capable of rescuing these phenotypes, but this activity is abolished by P155L, establishing it as a functionally damaging allele. Our results establish a rare TM2D3 variant in association with LOAD susceptibility, and together with prior work suggests possible links to the β-amyloid cascade.


  • Genetic and Molecular Epidemiology
  • EpiHealth: Epidemiology for Health

Publishing year





PLoS Genetics





Document type

Journal article


Public Library of Science


  • Medical Genetics



Research group

  • Genetic and Molecular Epidemiology


  • ISSN: 1553-7390